BREAKING: Big Pharma Paid $690 Million To Fauci’s Agency Through Secret Third Party Royalties During Pandemic Years

Payments to Dr. Anthony Fauci’s agency and colleagues from private pharmaceutical firms under obscure licensing and royalty schemes skyrocketed during the pandemic.

The American people started to feel that Big Pharma was very close to Big Government. Thanks to our two federal lawsuits demanding transparency, we know more details and they do not inspire confidence.

In 2022 and 2023, pharmaceutical and healthcare companies paid the National Institutes of Health a sum of $710,381,160 in third party royalties. These were payments to NIH, its leadership and scientists by healthcare entities licensing inventions created in federal, taxpayer-paid labs. The two-year average of such payments over the prior decade was less than $5 million, for an increase of more than 175 times.

Fauci’s institute, The National Institute of Allergies and Infectious Diseases (NIAID) received $690,218,610 of the $710 million, or 97%. In the same period, the other 26 institutes under the NIH received some $26 million in total.

It was an extreme cash haul at Fauci’s institute:

Between 2009-2021, OpenTheBooks.com, the organization I founded and lead, previously reported that $325 million was paid to all NIH institutes. Fauci’s NIAID received $23.9 million of that – or an average of $2 million per year.